TGFB1 and pulmonary fibrosis: Of the remaining hits from our screen, RepSox anti-TGFβ pathway activity is clearly an established target for lung fibrosis;45,46 however, clinical trials of small-molecule and biological inhibitors of TGFβ signaling have not resulted in approved therapeutics.47